Pinned Tweet
📚✨ A proud decade of academic contribution by the @pcrrticonic Group!
Four landmark books shaping #PediatricNephrology & #CriticalCare worldwide:
1️⃣ Critical Care Pediatric Nephrology & Dialysis Protocols Handbook
2️⃣ Advances in Critical Care Pediatric Nephrology: #POCUS
3️⃣ Atlas of Radiology in Pediatric Kidney Disorders
4️⃣ Pediatric Solid Organ Transplantation Protocols Handbook
🌍 Strengthening global education, practice & collaboration!
#PCRRT #ICONIC #KidneyCare #PedsNephrology #Transplant #pcrrticonic #pcrrtadvances #CriticalCare #criticalcarenephrology @rupeshrainamd @MignonMcCulloch @TBunchman @kalhasanksu @sumersethi #MedTwitter @pednephrol @IPNA_PedNeph @isn_india @asian_PNA @ASPNeph @medicosmcqs @DrDhruvchauhan @IptaPedsTx @StarzlT @Alanepe1 @valerie_luyckx @drshyambansal @MedEdMahan @ahusindia @catochita @deepti_bahl @CharuThakar @arvindcanchi @drkafeelkhan @JasmineNephro @drkeithsiau @luck_urine @edgarvlermamd @MushtaqBilalPhD @NephroP @ISBP_ @Narayansgpgims @theliverdoc @ifkf_wka @AnandhUrmila @Vasuragh @minnie_sarwal @DevarajanPrasad @DDD_Askenazi
sidsdoc retweeted
FORDA has urged Hon’ble Minister Shri Ashwini Vaishnaw to review “SURYAA -Ant Se Aarambh Tak” over its portrayal of doctors.
We oppose unethical practices, but individual misconduct must not malign an entire profession.
Protect doctors’ dignity. Safeguard public trust.
#Doctor
The Indian Medical Association (IMA) has written to Ashwini Vaishnaw, Minister for Information and Broadcasting, seeking an urgent review of the film “Suryaa– Ant Se Aarambh Tak” over its portrayal of the medical profession and violence against healthcare workers.
sidsdoc retweeted
Copy of letter dated October 22, 2026 written to @AshwiniVaishnaw , Hon’ble Minister for Information & Broadcasting, Ministry of Information and Broadcasting Government of India.
sidsdoc retweeted
The Indian Medical Association (IMA) has written to the Union Information and Broadcasting Ministry to urgently review the promotional content of Sunny Deol-starrer Suryaa – Ant Se Aarambh Tak, alleging that it generalises corruption in the medical profession and depicts violence against healthcare workers in ways that could erode public trust and put doctors’ safety at risk. #IMA #DoctorsSafety #HealthcareWorkers #MedicalProfession #SunnyDeol #Suryaa #PublicTrust #Healthcare #india
Honoured to be invited to the Pediatric Transplantation Session (@IndiaSoTx In Collaboration with @IptaPedsTx )at the 36th Annual Conference of the Indian Society of Organ Transplantation in Hyderabad.
I spoke on “Difficult Cases of Recurrent FSGS” and had the privilege of moderating a panel discussion on “Perioperative Care in Pediatric Heart, Kidney & Liver Transplantation,” featuring some of the country’s most eminent transplant specialists.
An excellent, well-attended educational session with insightful discussions and valuable shared learning. My sincere thanks to the organisers, fellow faculty and delegates for making it such an enriching experience.
@IPNA_Congress @LittleKidneys @IPNA_PedNeph @ttsorg @drneelam03 @rupeshrainamd @kalhasanksu @saudi_SSN @pcrrticonic @isn_india @kidneydelhi @ISOT2025 @LarsPape2 @IndiaSoTx @academy_twin @iapindia @sumersethi #drsidharthsethi #pediatricnephrology #pediatrickidneytransplant @SPLIT_TTS @HospitalArtemis – at Hyderabad, India
🏅 NOBEL PRIZE 2026 — A NEET/INICET-PG REVISION ALERT! 🧠💡
The 2026 Nobel Prize in Physiology or Medicine honours Karl Deisseroth, Peter Hegemann and Georg Nagel for discoveries concerning light-gated ion channels and optogenetics.
📚 Remember these exam points:
🔹 Optogenetics: Uses light to control the activity of genetically modified cells, particularly neurons.
🔹 Channelrhodopsin: A light-gated ion channel discovered in green algae. Its expression in neurons enables optical control of neuronal activity
🔹 Peter Hegemann & Georg Nagel: Discovered and characterised channelrhodopsins.
🔹 Karl Deisseroth: Developed their use as light-controlled switches for neurons, transforming neuroscience research.
🧠 Memory hook:
Green algae → Channelrhodopsin → Light → Neuronal activation
🎯 Possible MCQ:
Control of genetically modified neurons using light is called:
A. Electrophysiology
B. Optogenetics
C. Chemogenetics
D. Neurography
✅ Answer: B. Optogenetics
📌 Save this post for revision and share it with your study group!
#NEETPG #NEETPG2027 #NEETPGPreparation #NEETPGRevision #INICET #INICETPreparation #NEXTExam #FMGE #MBBS #MedicalStudents #MedicalEducation #MedEd #NobelPrize #NobelPrize2026 #NobelPrizeInMedicine #Optogenetics #Channelrhodopsin #Neuroscience #Neurophysiology #Physiology #Neurology #KarlDeisseroth #PeterHegemann #GeorgNagel #HighYield #MedicalMCQ #DAMS #DAMSDelhi #DAMSApp
sidsdoc retweeted
Great news!!!
Finally Goverment of India bans Paraquat!!
All the people who supported the cause, kudos!! Long battle of raisng awareness to finally see this ban feels surreal #paraquatban #doctorsagainstparaquat @vinay_vangala
Most dreaded call for admission..
You just helplessly watch
Paraquat #MedTwitter a lady consumed half a bottle..prayers
It was a profound honour and privilege to deliver the 8th Dr. C. Subhakara Rao Memorial Oration yesterday at Vijayawada, Andhra Pradesh, on “Advances in Critical Care Pediatric Nephrology.”
Dr. Chinthapalli Subhakara Rao was a respected senior paediatrician, a pioneer of paediatrics in Andhra Pradesh, and a compassionate physician who devoted his life to his patients, the medical profession and society. His remarkable contributions to the IAP, IMA and medical education continue to inspire generations of doctors.
I remain deeply grateful to the IAP Krishna District Branch, Bezawada Medical Association and IMA Vijayawada for bestowing upon me the honour of delivering an oration instituted in the memory of such an eminent and beloved physician.
@aiims_newdelhi @UCMSofficial @kidneydelhi @isn_india @IndiaSoTx @HospitalArtemis @rupeshrainamd @kalhasanksu @saudi_SSN @IapNrc @GurugramIap @iapindia @DelhiIap @sumersethi @deepti_bahl @pcrrticonic @IPNA_Congress @LittleKidneys @IPNA_PedNeph @AlshamiAlanoud @Alanepe1 @DrDhruvchauhan @kamaldshah @drshyambansal @valerie_luyckx @pednephrol @ISNkidneycare – at Vijayawada, India
The IAP Pediatric Nephrology Chapter cordially invites you to an academic webinar on “Voiding Dysfunction.”
🎙️ Speaker: Dr Jyoti Sharma, Councillor AsPNA & Consultant Pediatric Nephrologist, KEM Hospital, Pune
👩⚕️ Chairperson: Lt Gen Madhuri Kanitkar (Retd)
📅 Thursday, 17 September 2026
⏰ 4:00–5:00 PM
Join us for an insightful and clinically relevant discussion. All pediatricians, pediatric nephrologists, residents and interested delegates are warmly invited!
🔗 Zoom link:
Link to Join is here
us06web.zoom.us/j/8196560604…
@pcrrticonic @IPNA_Congress @LittleKidneys @IPNA_PedNeph @Alanepe1 @rupeshrainamd @kalhasanksu @saudi_SSN @IapNrc @GurugramIap @iapindia
@academy_twin @AAPGlobalHealth @AAPNews @AAPneonatal @ASPNeph @AspnResearch @EspnYpnn @ESPNSociety @isn_india @ISNWCN @CharuMalik_ISN @ISNkidneycare
Pleased to share that this month we published the validation of the STARZ Neonatal AKI Risk Stratification in a VLBW cohort from the United States in the journal @Ped_Research .
The findings highlight a critical need for more neonatal sub-group population-oriented risk stratification scores to improve clinical outcomes.
You can access the full publication here: nature.com/articles/s41390-0…
@rupeshrainamd @pcrrticonic @isn_india @ISNWCN @CharuMalik_ISN @Kidney_Int @Ped_Research @IPNA_Congress @LittleKidneys @IPNA_PedNeph @AlshamiAlanoud @kalhasanksu @GurugramIap @IapNrc @DelhiIap @iapindia @AAPneonatal @metrohealthCLE @Ped_Neph @AmerAcadPeds @wazir_sanjay
An honour to be part of largest publication on HNF-4A Fanconi syndrome published this week in @KIReports ! This is an extremely rare disease with our case being the only case published ever from India: a rare progression Neonatal Hypoglycemia, Hyperinsulinism—-> Fanconi Syndrome—-> MODY early. Thanks to the collaborators ! @IPNA_Congress @AmerAcadPeds @IPNA_PedNeph @EspnYpnn @Alanepe1 @md_rupesh @rupeshrainamd @pcrrticonic @kalhasanksu @saudi_SSN
Link to full text kireports.org/article/S2468-…
sidsdoc retweeted
pubmed.ncbi.nlm.nih.gov/4232… Nice article from LMIC PCRRT ICONIC group @sidsdoc @IPNA_PedNeph @IptaPedsTx @ISNkidneycare @ASNKidney @ASPNeph @pcrrticonic @AkronChildrens @NEOMEDedu
sidsdoc retweeted
Absolutely practice changing!! One of the most stunning developments in the treatment of patients with metastatic pancreatic cancer !! It is one of the rare moments in oncology which you will always remember ! Like the imatinib, trastuzumab presentations @ASCO #ASCO26 @OncoAlert
sidsdoc retweeted
The breakthrough isn’t the median survival rate doubling, it’s the fact that they’ve finally managed to create a drug that can target the RAS(on) state, rather than selective KRAS mutations. This makes it the first multi selective RAS inhibitor that’s clinically proven to work. The implications are huge. KRAS mutations are found in:
1. 90% of pancreatic cancers
2. 40-50% of colorectal
3. 20-40% lung
4. 19-23% of ALL cancers
Cheers, chills, and a standing ovation when RASolute 302 showed unprecedented survival on daraxonrasib for patients with progressive pancreatic cancer
Seldom do you sense you’re witnessing a historic moment in cancer care but this feels like ras targeting has arrived
#ASCO26
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO

ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
A public interest litigation has been filed in the Supreme Court challenging the new Central Board of Secondary Education (CBSE) policy mandating the teaching of two compulsory languages for Ninth-grade students.
Senior Advocate Mukul Rohatgi mentioned the PIL plea before the Supreme Court today, seeking that the PIL plea be heard by the Court soon. The senior lawyer stated that the plea has been filed by students, teachers and parents challenging the new policy CBSE.
"Suddenly, in the 9th standard, two languages have been made compulsory. Very different from what is happening. This will create chaos,” Rohatgi said.
A bench led by CJI Surya Kant has agreed to list the plea to be heard next week.
sidsdoc retweeted
Three language policy policy has no foresight and no vision the only purpose is to burden a child with extra syllabus.
Children would be learning 3 languages in 9-10th. That's like half of the syllabus, half of their time only to learn languages.
The country doesn't need art graduates, it needs engineers, doctors and scientists.
#amitkilhor #kilhor #threelanguage




































